Ogkologos

4398 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

EMA Recommends Granting a Marketing Authorisation for Nivolumab / Relatlimab

Ogkologos - 11 Αυγούστου, 2022

What to Know About Peer-Reviewed Cancer Information and Its Role in...

Ogkologos - 10 Αυγούστου, 2022

Help seeking: Why isn’t it as simple as it might sound?

Ogkologos - 10 Αυγούστου, 2022

Neoadjuvant Niraparib Demonstrates Promising Antitumour Activity and Safety in Patients with...

Ogkologos - 10 Αυγούστου, 2022

Trastuzumab Deruxtecan Shows High Intracranial Response Rate in Patients with Active...

Ogkologos - 9 Αυγούστου, 2022

How Being an Athlete Prepared Me for My Cancer Experience

Ogkologos - 9 Αυγούστου, 2022

Pembrolizumab Improves Survival in Advanced Triple-Negative Breast Cancer

Ogkologos - 9 Αυγούστου, 2022

Molecular Profiling Identifies Targetable Alterations in Majority of Patients with Advanced...

Ogkologos - 9 Αυγούστου, 2022

Largest Study on Frequent Aspirin Use Supports Reduction in Ovarian Cancer...

Ogkologos - 8 Αυγούστου, 2022

Genetic Risk Score Increases Prediction of Severe Obesity in Adult Survivors...

Ogkologos - 5 Αυγούστου, 2022

1...182183184...440 Σελίδα 183 από 440

MOST POPULAR

Pembrolizumab Now Second Immunotherapy Approved to Treat Merkel Cell Carcinoma

4 Φεβρουαρίου, 2019

Trial Results Confirm Effectiveness of Atezolizumab Against a Rare Sarcoma

20 Οκτωβρίου, 2023

Study in India Could Make Immunotherapy More Affordable Worldwide

22 Νοεμβρίου, 2022

As Winter Storms Plague Southern States, GreaterGood Is Helping Where It’s...

25 Φεβρουαρίου, 2021

Φόρτωση περισσοτέρων

EMA Recommends Granting a Marketing Authorisation for Nivolumab / Relatlimab

What to Know About Peer-Reviewed Cancer Information and Its Role in...

Help seeking: Why isn’t it as simple as it might sound?

Neoadjuvant Niraparib Demonstrates Promising Antitumour Activity and Safety in Patients with...

Trastuzumab Deruxtecan Shows High Intracranial Response Rate in Patients with Active...

How Being an Athlete Prepared Me for My Cancer Experience

Pembrolizumab Improves Survival in Advanced Triple-Negative Breast Cancer

Molecular Profiling Identifies Targetable Alterations in Majority of Patients with Advanced...

Largest Study on Frequent Aspirin Use Supports Reduction in Ovarian Cancer...

Genetic Risk Score Increases Prediction of Severe Obesity in Adult Survivors...

MOST POPULAR

Pembrolizumab Now Second Immunotherapy Approved to Treat Merkel Cell Carcinoma

Trial Results Confirm Effectiveness of Atezolizumab Against a Rare Sarcoma

Study in India Could Make Immunotherapy More Affordable Worldwide

As Winter Storms Plague Southern States, GreaterGood Is Helping Where It’s...

HOT NEWS

Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women...

Woman With Double Mastectomy Invents Breastfeeding Simulator For Breast Cancer Survivors

EMA Recommends Granting a Marketing Authorisation for Datopotamab Deruxtecan

Begin Each Day…

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ